South Korea is making waves across the globe – not just in music, but in cutting-edge biotechnology. From K-Pop hits topping international charts to innovative organoid research transforming drug discovery, the country is exporting both culture and science on a global scale.
K-Pop has mastered the art of crossing borders. Among Gen Alpha, one in four call it their favorite genre, driving its reach through streaming platforms, social media, and fandom rituals. Its influence now pops up in unexpected places, such as Wednesday Season 2, where Emma Myers’ character gushes over SEVENTEEN and a MAMAMOO track sets the scene. The animated Netflix film K-Pop Demon Hunters became one of 2025’s most-watched titles, adding to South Korea’s cultural export power.
K-Pop Demon Hunters, Netflix
In biotechnology, South Korea’s organoid research is having its own K-Pop moment. The country is emerging as a leader in organoid-based drug discovery, with companies like Samsung Biologics offering organoid drug screening services, and startups such as OrganoidSciences developing patient-derived organoid platforms through its ODISEI system. With a 2025 IPO and a partnership with Germany’s Lambda Biologics, the company is positioning itself for international expansion.
Academic teams at POSTECH and UNIST are developing scalable organoid production platforms, reducing reliance on animal testing and accelerating drug discovery. Both K-Pop and South Korea’s biotech sector show how a mix of local identity, global networking, and precision execution can turn niche ideas into worldwide movements.
Read more:
